Hormone replacement therapy: to use or not to use?

Area of Science:

• Reproductive Endocrinology
• Gerontology
• Pharmacology

Background:

• Hormone replacement therapy (HRT) is primarily indicated for managing menopausal symptoms and enhancing quality of life.
• Osteoporosis management is a key consideration, with HRT demonstrating efficacy in reducing fracture risk, especially in symptomatic women.

Purpose of the Study:

• To evaluate the established indications for hormone replacement therapy (HRT).
• To assess the risks and benefits associated with HRT, including its impact on cardiovascular health, bone density, and cancer incidence.
• To provide guidance on the optimal duration and ongoing management of HRT.

Main Methods:

• Review of clinical guidelines and evidence regarding hormone replacement therapy (HRT).
• Analysis of HRT's effects on menopausal symptoms, bone health, cardiovascular outcomes, and cancer risk.
• Emphasis on patient-specific risk-benefit assessments and regular medical review.

Main Results:

• HRT is effective for menopausal symptom control and osteoporosis prevention.
• HRT is not recommended for cardioprotection.
• HRT is associated with a slight increase in breast cancer incidence and a higher risk of thromboembolism, both correlating with therapy duration and patient age.

Conclusions:

• Hormone replacement therapy (HRT) offers significant benefits for menopausal symptoms and osteoporosis but requires careful consideration of associated risks.
• Optimal HRT duration is typically 4-5 years, with annual reviews essential for risk-benefit counseling.
• Patient management necessitates ongoing evaluation to ensure therapy remains appropriate and safe.